Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,974 | 30,278 | 10,973 | -9,344 | -4,815 |
| Depreciation Amortization | 2,796 | 11,524 | 8,683 | 5,805 | 2,897 |
| Income taxes - deferred | N/A | -7,075 | N/A | N/A | N/A |
| Accounts receivable | 6,626 | 16,345 | -6,685 | 19,805 | 23,143 |
| Accounts payable and accrued liabilities | 517 | -1,380 | 620 | 6,611 | 2,075 |
| Other Working Capital | -4,397 | -3,535 | -2,717 | 11,446 | 10,677 |
| Other Operating Activity | -4,904 | -7,239 | 12,437 | -22,050 | -22,731 |
| Operating Cash Flow | $3,612 | $38,918 | $23,311 | $12,273 | $11,246 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61 | -56 | -40 | -20 | N/A |
| Purchase Of Investment | -12,507 | -76,230 | -60,956 | -44,892 | -24,974 |
| Sale Of Investment | 14,099 | 55,848 | 42,878 | 26,535 | 5,894 |
| Investing Cash Flow | $1,531 | $-20,438 | $-18,118 | $-18,377 | $-19,080 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,110 | -33,330 | -22,220 | -11,110 | N/A |
| Common Stock Issued | N/A | 150 | 150 | N/A | N/A |
| Other Financing Activity | -222 | -666 | -445 | -222 | 0 |
| Financing Cash Flow | $-11,332 | $-33,846 | $-22,515 | $-11,332 | $N/A |
| Beginning Cash Position | 71,310 | 86,676 | 86,676 | 86,676 | 86,676 |
| End Cash Position | 65,121 | 71,310 | 69,354 | 69,240 | 78,842 |
| Net Cash Flow | $-6,189 | $-15,366 | $-17,322 | $-17,436 | $-7,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,612 | 38,918 | 23,311 | 12,273 | 11,246 |
| Capital Expenditure | -61 | -56 | -40 | -20 | N/A |
| Free Cash Flow | 3,551 | 38,862 | 23,271 | 12,253 | 11,246 |